Progress in corticotropin-releasing factor-1 antagonist development
- 31 May 2010
- journal article
- review article
- Published by Elsevier BV in Drug Discovery Today
- Vol. 15 (9-10), 371-383
- https://doi.org/10.1016/j.drudis.2010.02.011
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- A Role for Brain Stress Systems in AddictionNeuron, 2008
- Integration of in vivo and in vitro approaches to characterize the toxicity of Antalarmin, a corticotropin-releasing hormone receptor antagonistToxicology, 2008
- MPZP: A novel small molecule corticotropin-releasing factor type 1 receptor (CRF1) antagonistPharmacology Biochemistry and Behavior, 2008
- CRF1 receptor antagonists attenuate escalated cocaine self-administration in ratsPsychopharmacology, 2007
- Achieving signalling selectivity of ligands for the corticotropin-releasing factor type 1 receptor by modifying the agonist's signalling domainBritish Journal of Pharmacology, 2007
- Physiology, pharmacology, and therapeutic relevance of urocortins in mammals: Ancient CRF paralogsFrontiers in Neuroendocrinology, 2007
- Dependence-induced increases in ethanol self-administration in mice are blocked by the CRF1 receptor antagonist antalarmin and by CRF1 receptor knockoutPharmacology Biochemistry and Behavior, 2007
- Corticotropin-Releasing Factor 1 Antagonists Selectively Reduce Ethanol Self-Administration in Ethanol-Dependent RatsBiological Psychiatry, 2007
- Evidence that corticotropin‐releasing factor receptor type 1 couples to Gs‐ and Gi‐proteins through different conformations of its J‐domainBritish Journal of Pharmacology, 2006
- Variation at the rat Crhr1 locus and sensitivity to relapse into alcohol seeking induced by environmental stressProceedings of the National Academy of Sciences of the United States of America, 2006